Showing 26,221 - 26,240 results of 70,370 for search '(( 50 ((a decrease) OR (we decrease)) ) OR ( a ((point decrease) OR (mean decrease)) ))', query time: 1.20s Refine Results
  1. 26221

    Multiwavelength Phototactic Micromotor with Controllable Swarming Motion for “Chemistry-on-the-Fly” by Yang Hu (315392)

    Published 2020
    “…Namely, under light irradiation, the photogenerated heat on Fe<sub>3</sub>O<sub>4</sub> NPs decreases the density of the irradiated spot, leading to the swarming motion of the composite particles propelled by a “hydrodynamic drag” toward the light spot. …”
  2. 26222

    Multiwavelength Phototactic Micromotor with Controllable Swarming Motion for “Chemistry-on-the-Fly” by Yang Hu (315392)

    Published 2020
    “…Namely, under light irradiation, the photogenerated heat on Fe<sub>3</sub>O<sub>4</sub> NPs decreases the density of the irradiated spot, leading to the swarming motion of the composite particles propelled by a “hydrodynamic drag” toward the light spot. …”
  3. 26223

    Multiwavelength Phototactic Micromotor with Controllable Swarming Motion for “Chemistry-on-the-Fly” by Yang Hu (315392)

    Published 2020
    “…Namely, under light irradiation, the photogenerated heat on Fe<sub>3</sub>O<sub>4</sub> NPs decreases the density of the irradiated spot, leading to the swarming motion of the composite particles propelled by a “hydrodynamic drag” toward the light spot. …”
  4. 26224
  5. 26225
  6. 26226
  7. 26227
  8. 26228
  9. 26229

    Data_Sheet_1_Case Report: Training Monitoring and Performance Development of a Triathlete With Spinal Cord Injury and Chronic Myeloid Leukemia During a Paralympic Cycle.zip by Oliver J. Quittmann (12653079)

    Published 2022
    “…Increased volumes at low intensity are assumed to increase P<sub>OBLA</sub> and decrease V˙Lamax over time. CML treatment and side effects drastically decreased TL, intensity, and performance, which ultimately hindered a qualification for Tokyo 2020/21. …”
  10. 26230

    Data_Sheet_1_Case Report: Training Monitoring and Performance Development of a Triathlete With Spinal Cord Injury and Chronic Myeloid Leukemia During a Paralympic Cycle.zip by Oliver J. Quittmann (12653079)

    Published 2022
    “…Increased volumes at low intensity are assumed to increase P<sub>OBLA</sub> and decrease V˙Lamax over time. CML treatment and side effects drastically decreased TL, intensity, and performance, which ultimately hindered a qualification for Tokyo 2020/21. …”
  11. 26231
  12. 26232
  13. 26233

    Flow chart of the study participants. by Milton W. Musaba (8431944)

    Published 2025
    “…We enrolled 150 mother-infant dyads into a pre-post study. …”
  14. 26234

    Suggested modifications for the BabySaver. by Milton W. Musaba (8431944)

    Published 2025
    “…We enrolled 150 mother-infant dyads into a pre-post study. …”
  15. 26235
  16. 26236

    Ku0063794 and temsirolimus inhibited tumor growth in a xenograft model of RCC. by Hao Zhang (15339)

    Published 2013
    “…<p>(<b>A</b>) The treatment with Ku0063794 or temsirolimus significantly inhibited tumor growth in Nu/Nu nude mice. …”
  17. 26237

    The predicted artificial flux as a function of stirring sensitivity and Reynolds stress. by Moritz Holtappels (448859)

    Published 2015
    “…As a first approximation, the fluctuating velocities (<i>u’</i>) around their mean (</p><p></p><p></p><p><mi>u</mi><mo>¯</mo></p><p></p><p></p>) can be transferred to the fluctuating concentrations (<i>c’</i>) around their mean (<p></p><p></p><p><mi>c</mi><mo>¯</mo></p><p></p><p></p>) using the slope of the function at <p></p><p></p><p><mi>u</mi><mo>¯</mo></p><p></p><p></p> as a transfer factor (red lines in A). …”
  18. 26238
  19. 26239

    Traction force dynamics in HBSM cells subjected to a transient stretch. by Cheng Chen (136164)

    Published 2013
    “…<p>(A) Cell traction map before stretch. (B) Traction map immediately after a 10% homogeneous biaxial tensile stretch of a 4s duration. …”
  20. 26240

    Longitudinal Serum Proteomics Characterization of CD19-CAR‑T Cell Therapy for B‑Cell Malignancies by Youming Wang (610986)

    Published 2023
    “…Hence, APOA1 has been selected as a potential biomarker of the CRS disease progression. …”